Reflections on the Cost of 'Low Cost' Whole Genome Sequencing : Framing the Health Policy Debate
The cost of whole genome sequencing is dropping rapidly. There has been a great deal of enthusiasm about the potential for this technological advance to transform clinical care. Given the interest and significant investment in genomics, this seems an ideal time to consider what the evidence tells us about potential benefits and harms, particularly in the context of health care policy. The scale and pace of adoption of this powerful new technology should be driven by clinical need, clinical evidence, and a commitment to put patients at the centre of health care policy
Year of publication: |
2014
|
---|---|
Authors: | Caulfield, Timothy ; Evans, James P. ; McGuire, Amy L. ; McCabe, Christopher ; Bubela, Tania ; Cook-Deegan, Bob ; Fishman, Jennifer ; Hogarth, Stuart ; Miller, Fiona A. ; Ravitsky, Vardit ; Biesecker, Barbara ; Borry, Pascal ; Cho, Mildred K. ; Carroll, June ; Etchegary, Holly ; Joly, Yann ; Kato, Kazuto ; Lee, Sandra ; Rothenberg, Karen H. ; Sankar, Pamela ; Szego, Michael ; Ossorio, Pilar ; Pullman, Daryl ; Rousseau, Francois ; Ungar, Wendy ; Wilson, Brenda |
Publisher: |
[S.l.] : SSRN |
Saved in:
freely available
Extent: | 1 Online-Ressource (6 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | In: PLOS Biology, V. 11, No. 11, November 2013, p. e1001699 Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments November 1, 2013 erstellt |
Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10014151972
Saved in favorites
Similar items by person
-
Wolf, Susan M., (2012)
-
Is genetic makeup a perceived health risk: analysis of a national survey of Canadians
Etchegary, Holly, (2009)
-
The Next Controversy in Genetic Testing : Clinical Data as Trade Secrets?
Cook-Deegan, Bob, (2014)
- More ...